Sangamo Biosciences reported $0 in Loan Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acceleron Pharma XLRN:US $ 0M 0M
Alnylam Pharmaceuticals ALNY:US $ 433.8M 0.65M
Amgen AMGN:US $ 33291M 4833M
Avrobio Inc AVRO:US $ 0 0
Bayer BAYN:GR € 36974M 310M
Biogen BIIB:US $ 6272.3M 996.9M
Biomarin Pharmaceutical BMRN:US $ 1078.09M 0.98M
Bluebird Bio BLUE:US $ 0M 0M
GlaxoSmithKline GSK:LN 20736M 294M
IONIS PHARMACEUT IONS:US $ 1303M 62.3M
Karyopharm Therapeutics KPTI:US $ 301.57M 195K
Novartis NOVN:VX SF 24715M 1776M
Omeros OMER:US $ 313.02M 433K
Sangamo Biosciences SGMO:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1094.91M 1.93M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 513.26M 11.67M